logo
  • ABOUT US
    • Our Mission
    • Our History
    • Our Team
    • Gallery
    • Vacancies
  • ABOUT AUTISM
    • What is autism
    • Epidemiology
    • Etiology – causes of the disease
    • Early symptoms
    • Screening
    • Diagnostics
    • What to do after an autism diagnosis ?
      • Early intervention
      • Assisting organizations
      • Where to seek help
      • Collaborations
    • Interventions
      • Applied Behavior Analysis (ABA)
    • Associated medical conditions
    • Prognosis
    • Education of children with autism
    • Families with children with ASD
    • Employment of people with autism
  • RESEARCH
    • Projects
    • Grants
    • Publications
    • Collaborations
    • Cooperation offer
  • SCREENING
    • M-CHAT
  • DIAGNOSTICS
  • EDUCATION
    • ADOS-2 course
    • Lectures and workshops
    • PhD. students
    • Graduates
  • SUPPORT US
  • MEDIA
    • Conferences
    • Books
  • NEWS
  • CONTACT
  • English
    • Slovak
  • ABOUT US
    • Our Mission
    • Our History
    • Our Team
    • Gallery
    • Vacancies
  • ABOUT AUTISM
    • What is autism
    • Epidemiology
    • Etiology – causes of the disease
    • Early symptoms
    • Screening
    • Diagnostics
    • What to do after an autism diagnosis ?
      • Early intervention
      • Assisting organizations
      • Where to seek help
      • Collaborations
    • Interventions
      • Applied Behavior Analysis (ABA)
    • Associated medical conditions
    • Prognosis
    • Education of children with autism
    • Families with children with ASD
    • Employment of people with autism
  • RESEARCH
    • Projects
    • Grants
    • Publications
    • Collaborations
    • Cooperation offer
  • SCREENING
    • M-CHAT
  • DIAGNOSTICS
  • EDUCATION
    • ADOS-2 course
    • Lectures and workshops
    • PhD. students
    • Graduates
  • SUPPORT US
  • MEDIA
    • Conferences
    • Books
  • NEWS
  • CONTACT
  • English
    • Slovak

Archives

  • Domov
  •  
  • Archives
    • 12. MAY 2022
    Improvement of the Clinical and Psychological Profile of Patients with Autism after Methylcobalamin Syrup Administration

    Improvement of the Clinical and Psychological Profile of Patients with Autism after Methylcobalamin Syrup Administration

    AUTHORS: Čorejová, A., Fazekaš, T., Jánošíková, D., Repiský, J., Pospíšilová, V., Miková, M., Rauová, D., Ostatníková, D., Kyselovič, J., Hrabovská, A. ABSTRACT: (1) Background: Autism, also known as autism-spectrum disorder, is a pervasive developmental disorder affecting social skills and psychological status in particular. The complex etiopathogenesis of autism limits efficient therapy, which leads to problems

    Viac
    • Barbara Rašková
    • 2022,
    • 2022,
    • Publications
    • Publications
    • 14. JANUARY 2021
    The acute effect of psychosocial stress on the level of oxidative stress in children

    The acute effect of psychosocial stress on the level of oxidative stress in children

    AUTHORS: Janšáková, K., Belica, I., Rajčániová, E., Rajčáni, J., Kyselicová, K., Celušáková, H., Laznibatová, J. and Ostatníková, D. ABSTRACT: The effect of chronic stress on oxidative stress (OS) is commonly discussed while the effect of acute stress situation is not fully examined yet. The present study was aimed to analyse whether acute psychosocial strain causes

    Viac
    • Barbara Rašková
    • 2021,
    • Publications
    • 2. NOVEMBER 2020
    A novel UHPLC-MS method targeting urinary metabolomic markers for autism spectrum disorder

    A novel UHPLC-MS method targeting urinary metabolomic markers for autism spectrum disorder

    AUTHORS: Olešová, D., Galba, J., Piešťanský, J., Celušáková, H., Repiská, G., Babinská, K., Ostatníková, D., Katina, S. and Kováč, A. ABSTRACT: Autism spectrum disorder is a heterogeneous neurodevelopmental disease. Currently, no biomarker of this disease is known. Diagnosis is performed through observation, standardized behavioral scales, and interviews with parents. In practice, diagnosis is often delayed

    Viac
    • Barbara Rašková
    • 2020,
    • Publications
    • 1. MAY 2020
    A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder

    A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder

    AUTHORS: Olesova, D., Galba, J., Piestansky, J., Celusakova, H., Repiska, G., Babinska, K., Ostatnikova, D., Katina, S., Kovac, A.. ABSTRACT: Autism spectrum disorder is a heterogeneous neurodevelopmental disease. Currently, no biomarker of this disease is known. Diagnosis is performed through observation, standardized behavioral scales, and interviews with parents. In practice, diagnosis is often delayed toViac
    • acva
    • 2020,
    • Publications
© 2021 ACVA. Všetky práva vyhradené. Created by DREAMWEB
Súbory cookie používame, aby sme vám zaistili čo najlepší zážitok z našich webových stránok. Ak budete naďalej používať túto stránku, budeme predpokladať, že ste s ňou spokojní.OK